Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 12, 2026, 16:36Tagreed Alkaltham: Tranexamic Acid in PBM
-
Feb 12, 2026, 16:35Paul Lambis Announces Maria Hadjidemetriou as a Speaker at Cyprus Diaspora Forum
-
Feb 12, 2026, 16:34Rahul Bhargava: Breaking Myths About Bone Marrow Transplant
-
Feb 12, 2026, 16:29Arun V J: Can You Be A Doctor And Still Be Stupid?
-
Feb 12, 2026, 16:26Changing the Narrative Around PPH – End Postpartum Hemorrhage
-
Feb 12, 2026, 16:20Mahesan Subramaniam: The Protective Switch in Brain Immune Cells Could Slow Alzheimer’s Disease
-
Feb 12, 2026, 16:13Lale Tokgözoğlu: Top 10 Dyslipidemia Papers of 2025
-
Feb 12, 2026, 16:10Neelam Mohan: Breaking Down Anemia from Causes and Testing to Treatment and Prevention
-
Feb 12, 2026, 16:04Irma Bagdoniene: From Estimating Risk to Seeing Disease in Preventive Cardiology